The young Microsoft Azure specialist claims to have found “a dream team of founders” in Ghent.
You are here
Deliverect will use the capital injection to improve its home delivery software and strengthen its position.
The Flanders-based biotech company is developing a T-cell vaccine that could provide broader protection.
The 250,000 m2 logistics campus will house several companies and create 500 jobs at North Sea Port.
Through corporate venturing, NephroFlow become a Nipro company and can achieve rapid international growth.
The industrial company will channel EUR 15 million per year into the transformation of its Wilrijk site.
The former Newcomer of the Year Trophy winner plans to expand its lab capacity in Ghent to 850 m² by 2022.
BlueChem will offer these start-ups an ideal framework for accelerating sustainable chemistry innovations.
The tool enables customers to build their own avatars, allowing them to order the right clothing sizes.
Johnson & Johnson is starting clinical trials for a potential COVID-19 vaccine in both the US and Flanders.